体外药理研究员

面议

Apply for post

Minimum Education:

本科

Number of Recruits:

Experience requirements:

1-3年

Work area:

江苏省南京市浦口区

工作内容

1. 负责项目体外药效学试验和细胞功能学试验的具体执行，包括试剂的甄选、试验的执行与记录、Trouble-shooting分析等；
2. 试验内容包括但不局限于细胞培养、细胞分离、免疫细胞相关细胞因子检测、免疫细胞表型分析、基于细胞的ELISA、细胞增殖、细胞毒性、信号通路研究等；
3. 负责相关工作文件的撰写、跟踪、审阅等；
4. 配合其它团队共同推进项目；
5．公司安排的其他工作内容。

任职要求

1．拥有细胞生物学、免疫学、药理学、生物化学、分子生物学或领域相关专业的硕士学位，有免疫治疗相关领域的研究经历；
2．2年及以上从事临床前药物研发的工作经验，有体外药物筛选和药物体外药效学检测经验者优先；
3．掌握多种生物化学、细胞生物学和免疫学相关实验技术，熟悉细胞培养、细胞分离、细胞刺激、细胞增殖、细胞毒性、免疫细胞功能试验以及ELISA试验等相关技术者优先；
4．具备良好的问题解决能力，掌握实验设计和数据分析相关的知识；
5．能够独立操作实验、分析数据和撰写实验报告；
6．良好的沟通能力和团队协作能力。

Creating innovative, affordable medicines for all

Customer Service Hotline

025-58883580

Address: 3F, Building E, Phase II, Zhongdan Ecological Life Science Industrial Park, 3-1 Xinjihu Road, Jiangbei New District, Nanjing

Zip Code: 210000

Email: hr@iamabio.com

MESSAGE

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Business License

This website already supports IPV4 / IPV6 bidirectional access